HEADER GENE REGULATION 12-SEP-24 9GRU TITLE CRYSTAL STRUCTURE OF HRP-2 PWWP DOMAIN IN COMPLEX WITH COMPOUND 30 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOMA-DERIVED GROWTH FACTOR-RELATED PROTEIN 2; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: HDGF-RELATED PROTEIN 2,HRP-2,HEPATOMA-DERIVED GROWTH FACTOR COMPND 5 2,HDGF-2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HDGFL2, HDGF2, HDGFRP2, HRP2, UNQ785/PRO1604; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, GENE REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR E.M.OSIPOV,T.PAULOVCAKOVA,S.BEELEN,T.VANTIEGHEM,S.V.STRELKOV REVDAT 1 06-NOV-24 9GRU 0 JRNL AUTH T.VANTIEGHEM,N.A.ASLAM,E.M.OSIPOV,M.AKELE,S.VAN BELLE, JRNL AUTH 2 S.BEELEN,M.DREXLER,T.PAULOVCAKOVA,V.LUX,D.FEARON, JRNL AUTH 3 A.DOUANGAMATH,F.VON DELFT,F.CHRIST,V.VEVERKA,P.VERWILST, JRNL AUTH 4 A.VAN AERSCHOT,Z.DEBYSER,S.V.STRELKOV JRNL TITL RATIONAL FRAGMENT-BASED DESIGN OF COMPOUNDS TARGETING THE JRNL TITL 2 PWWP DOMAIN OF THE HRP FAMILY. JRNL REF EUR.J.MED.CHEM. V. 280 16960 2024 JRNL REFN ISSN 0223-5234 JRNL PMID 39461037 JRNL DOI 10.1016/J.EJMECH.2024.116960 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.21.1_5286: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 79.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 31291 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.259 REMARK 3 R VALUE (WORKING SET) : 0.257 REMARK 3 FREE R VALUE : 0.302 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.190 REMARK 3 FREE R VALUE TEST SET COUNT : 1625 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 79.9800 - 3.9000 1.00 2673 137 0.2466 0.2732 REMARK 3 2 3.9000 - 3.0900 1.00 2509 149 0.2367 0.2775 REMARK 3 3 3.0900 - 2.7000 1.00 2500 139 0.2691 0.3001 REMARK 3 4 2.7000 - 2.4600 1.00 2484 112 0.2740 0.3590 REMARK 3 5 2.4600 - 2.2800 1.00 2468 133 0.2594 0.3212 REMARK 3 6 2.2800 - 2.1400 1.00 2485 108 0.2653 0.3539 REMARK 3 7 2.1400 - 2.0400 1.00 2449 123 0.2653 0.3416 REMARK 3 8 2.0400 - 1.9500 1.00 2418 144 0.2571 0.3060 REMARK 3 9 1.9500 - 1.8700 1.00 2405 176 0.2596 0.3343 REMARK 3 10 1.8700 - 1.8100 1.00 2419 137 0.2695 0.3475 REMARK 3 11 1.8100 - 1.7500 1.00 2432 142 0.3123 0.3444 REMARK 3 12 1.7500 - 1.7000 1.00 2424 125 0.3619 0.4284 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.480 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2309 REMARK 3 ANGLE : 0.823 3126 REMARK 3 CHIRALITY : 0.053 278 REMARK 3 PLANARITY : 0.007 412 REMARK 3 DIHEDRAL : 16.743 860 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9GRU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-SEP-24. REMARK 100 THE DEPOSITION ID IS D_1292141077. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-FEB-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91165 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31362 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 79.980 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.60 REMARK 200 R MERGE (I) : 0.08700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 14.10 REMARK 200 R MERGE FOR SHELL (I) : 1.83300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.2 M AMMONIUM SULFATE, 0.2 M AMMONIUM REMARK 280 IODIDE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.54550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.97750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.99400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.97750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.54550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 20.99400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 SER A 93 REMARK 465 GLY B 0 REMARK 465 GLY C 0 REMARK 465 MET C 1 REMARK 465 PRO C 2 REMARK 465 ILE C 28 REMARK 465 ALA C 29 REMARK 465 ASP C 30 REMARK 465 GLY C 31 REMARK 465 ALA C 32 REMARK 465 VAL C 33 REMARK 465 LYS C 34 REMARK 465 PRO C 35 REMARK 465 PRO C 36 REMARK 465 SER C 93 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 73 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 CYS A 64 CA CB SG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS C 73 O HOH C 201 2.07 REMARK 500 O HOH B 212 O HOH B 218 2.09 REMARK 500 NZ LYS A 16 O HOH A 201 2.10 REMARK 500 O HOH A 201 O HOH A 205 2.10 REMARK 500 OD1 ASP A 27 O HOH A 202 2.11 REMARK 500 O HOH A 232 O HOH A 250 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 87 65.87 -156.62 REMARK 500 HIS B 3 -169.81 -113.84 REMARK 500 ASN B 87 66.89 -152.03 REMARK 500 TYR B 92 58.16 -113.72 REMARK 500 ASN C 87 53.91 -141.03 REMARK 500 ALA C 90 -151.85 -78.90 REMARK 500 REMARK 500 REMARK: NULL DBREF 9GRU A 1 93 UNP Q7Z4V5 HDGR2_HUMAN 1 93 DBREF 9GRU B 1 93 UNP Q7Z4V5 HDGR2_HUMAN 1 93 DBREF 9GRU C 1 93 UNP Q7Z4V5 HDGR2_HUMAN 1 93 SEQADV 9GRU GLY A 0 UNP Q7Z4V5 EXPRESSION TAG SEQADV 9GRU GLY B 0 UNP Q7Z4V5 EXPRESSION TAG SEQADV 9GRU GLY C 0 UNP Q7Z4V5 EXPRESSION TAG SEQRES 1 A 94 GLY MET PRO HIS ALA PHE LYS PRO GLY ASP LEU VAL PHE SEQRES 2 A 94 ALA LYS MET LYS GLY TYR PRO HIS TRP PRO ALA ARG ILE SEQRES 3 A 94 ASP ASP ILE ALA ASP GLY ALA VAL LYS PRO PRO PRO ASN SEQRES 4 A 94 LYS TYR PRO ILE PHE PHE PHE GLY THR HIS GLU THR ALA SEQRES 5 A 94 PHE LEU GLY PRO LYS ASP LEU PHE PRO TYR ASP LYS CYS SEQRES 6 A 94 LYS ASP LYS TYR GLY LYS PRO ASN LYS ARG LYS GLY PHE SEQRES 7 A 94 ASN GLU GLY LEU TRP GLU ILE GLN ASN ASN PRO HIS ALA SEQRES 8 A 94 SER TYR SER SEQRES 1 B 94 GLY MET PRO HIS ALA PHE LYS PRO GLY ASP LEU VAL PHE SEQRES 2 B 94 ALA LYS MET LYS GLY TYR PRO HIS TRP PRO ALA ARG ILE SEQRES 3 B 94 ASP ASP ILE ALA ASP GLY ALA VAL LYS PRO PRO PRO ASN SEQRES 4 B 94 LYS TYR PRO ILE PHE PHE PHE GLY THR HIS GLU THR ALA SEQRES 5 B 94 PHE LEU GLY PRO LYS ASP LEU PHE PRO TYR ASP LYS CYS SEQRES 6 B 94 LYS ASP LYS TYR GLY LYS PRO ASN LYS ARG LYS GLY PHE SEQRES 7 B 94 ASN GLU GLY LEU TRP GLU ILE GLN ASN ASN PRO HIS ALA SEQRES 8 B 94 SER TYR SER SEQRES 1 C 94 GLY MET PRO HIS ALA PHE LYS PRO GLY ASP LEU VAL PHE SEQRES 2 C 94 ALA LYS MET LYS GLY TYR PRO HIS TRP PRO ALA ARG ILE SEQRES 3 C 94 ASP ASP ILE ALA ASP GLY ALA VAL LYS PRO PRO PRO ASN SEQRES 4 C 94 LYS TYR PRO ILE PHE PHE PHE GLY THR HIS GLU THR ALA SEQRES 5 C 94 PHE LEU GLY PRO LYS ASP LEU PHE PRO TYR ASP LYS CYS SEQRES 6 C 94 LYS ASP LYS TYR GLY LYS PRO ASN LYS ARG LYS GLY PHE SEQRES 7 C 94 ASN GLU GLY LEU TRP GLU ILE GLN ASN ASN PRO HIS ALA SEQRES 8 C 94 SER TYR SER HET PYZ A 101 6 HET SO4 A 102 5 HET SO4 A 103 5 HET PYZ B 101 6 HET SO4 B 102 5 HET SO4 B 103 5 HET PYZ C 101 6 HET SO4 C 102 5 HETNAM PYZ 4-IODOPYRAZOLE HETNAM SO4 SULFATE ION FORMUL 4 PYZ 3(C3 H3 I N2) FORMUL 5 SO4 5(O4 S 2-) FORMUL 12 HOH *138(H2 O) HELIX 1 AA1 GLY A 54 LYS A 56 5 3 HELIX 2 AA2 TYR A 61 GLY A 69 1 9 HELIX 3 AA3 GLY A 76 ASN A 87 1 12 HELIX 4 AA4 GLY B 54 LYS B 56 5 3 HELIX 5 AA5 TYR B 61 GLY B 69 1 9 HELIX 6 AA6 GLY B 76 ASN B 87 1 12 HELIX 7 AA7 GLY C 54 LYS C 56 5 3 HELIX 8 AA8 CYS C 64 GLY C 69 1 6 HELIX 9 AA9 GLY C 76 ASN C 87 1 12 SHEET 1 AA1 5 THR A 50 LEU A 53 0 SHEET 2 AA1 5 TYR A 40 PHE A 44 -1 N ILE A 42 O ALA A 51 SHEET 3 AA1 5 TRP A 21 ILE A 25 -1 N ARG A 24 O PHE A 43 SHEET 4 AA1 5 LEU A 10 ALA A 13 -1 N VAL A 11 O ALA A 23 SHEET 5 AA1 5 LEU A 58 PRO A 60 -1 O PHE A 59 N PHE A 12 SHEET 1 AA2 5 THR B 50 LEU B 53 0 SHEET 2 AA2 5 TYR B 40 PHE B 44 -1 N ILE B 42 O ALA B 51 SHEET 3 AA2 5 TRP B 21 ILE B 25 -1 N ARG B 24 O PHE B 43 SHEET 4 AA2 5 LEU B 10 ALA B 13 -1 N VAL B 11 O ALA B 23 SHEET 5 AA2 5 LEU B 58 PRO B 60 -1 O PHE B 59 N PHE B 12 SHEET 1 AA3 5 THR C 50 LEU C 53 0 SHEET 2 AA3 5 TYR C 40 PHE C 44 -1 N ILE C 42 O ALA C 51 SHEET 3 AA3 5 TRP C 21 ILE C 25 -1 N ARG C 24 O PHE C 43 SHEET 4 AA3 5 LEU C 10 ALA C 13 -1 N ALA C 13 O TRP C 21 SHEET 5 AA3 5 LEU C 58 PRO C 60 -1 O PHE C 59 N PHE C 12 CRYST1 41.091 41.988 159.955 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024336 0.000000 0.000000 0.00000 SCALE2 0.000000 0.023816 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006252 0.00000